A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma Digital Care Network in Patients With Multiple Myeloma MYHOPE

What's the purpose of this trial?

NDS-MM-004 is a multi-center, randomized, pilot trial to evaluate the MyHOPE for multiple myeloma Platform in patients with multiple myeloma. The MyHOPE for MM Platform is a validated investigational device manufactured by Amalgam Rx, Inc. and designed to provide patients with a comprehensive set of tools and resources to support the patient throughout their overall experience with multiple myeloma.

This trial is currently open and accepting patients.

Additional Trial Information

Observational Trial

Enrollment: 126 patients (estimated)

View More

You may be able to join this trial if you:

The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required. Create your account or call us today for help (888) 828-2206.

Inclusion Criteria:

  • Patient is ≥ 18 years old with a diagnosis of Multiple Myeloma
  • Patient must reside in the USA.
  • Patients within each of the following subgroups, at one of the following timepoints, will be eligible for entry:
    1. Newly-diagnosed multiple myeloma transplant-eligible
    2. Patients undergoing their first ASCT
    3. Newly-diagnosed multiple myeloma transplant-ineligible
    4. Relapsed and/or refractory.

Exclusion Criteria:

  • Patient has a condition(s) that, in the opinion of the Investigator, would make participation infeasible such as inability to provide informed consent, illiteracy, or inability to speak, read, and write in English.
  • Patient is on hospice.
  • Patient is receiving or has received an investigational agent < 28 days prior to randomization or during this pilot study.
View Additional Criteria

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.


University of South Alabama Mitchell Cancer Institute

Mobile, AL

Not Yet Accepting


Mayo Clinic (Arizona)

Phoenix, AZ

Not Yet Accepting


James R Berenson, MD, Inc.

West Hollywood, CA

Not Yet Accepting


Mayo Clinic (Jacksonville)

Jacksonville, FL

Not Yet Accepting


Winship Cancer Institute of Emory University

Atlanta, GA

Not Yet Accepting

Augusta University Medical Center

Augusta, GA

Not Yet Accepting


Innovation Clinical Research of the Pacific

Honolulu, HI

Open and Accepting


American Oncology Partners of Maryland, PA

Bethesda, MD

Not Yet Accepting


Massachusetts General Hospital

Boston, MA

Not Yet Accepting

Dana-Farber Cancer Institute

Boston, MA

Not Yet Accepting


West Michigan Cancer Center

Kalamazoo, MI

Not Yet Accepting

Newland Medical Associates (Southfield)

Southfield, MI

Not Yet Accepting


Mayo Clinic (Rochester)

Rochester, MN

Not Yet Accepting


Hattiesburg Clinic

Hattiesburg, MS

Not Yet Accepting

New York

Mount Sinai Hospital Tisch Cancer Institute

New York, NY

Not Yet Accepting

New York Cancer and Blood Specialists

Port Jefferson Station, NY

Open and Accepting

Rochester General Hospital

Rochester, NY

Not Yet Accepting

North Carolina

UNC Lineberger Comprehensive Cancer Center University of North Carolina

Chapel Hill, NC

Not Yet Accepting

Wake Forest Baptist Comprehensive Cancer Center Wake Forest School of Medicine

Winston-Salem, NC

Not Yet Accepting

Duke Cancer Center Duke University Medical Center

Durham, NC

Not Yet Accepting

Cone Health Cancer Center (Greensboro)

Greensboro, NC

Not Yet Accepting


Fox Chase Cancer Center Temple Health

Philadelphia, PA

Not Yet Accepting



Community Cancer Trials of Utah

Ogden, UT

Not Yet Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message

SparkCures Verified

SparkCures is working closely with Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb to provide the most up-to-date information on this clinical trial. Use the button above to add this trial to your list of favorites.

Learn more about how we work with trial sponsors